Acute angiotensin-converting enzyme inhibition increases the plasma level of the natural stem cell regulator N-acetyl-seryl-aspartyl-lysyl-proline

The Journal of Clinical Investigation
M AziziJ Ménard

Abstract

Angiotensin I-converting enzyme (ACE) has two homologous active NH2- and COOH-terminal domains and displays activity toward a broad range of substrates. The tetrapeptide N-acetyl-seryl-aspartyl-lysyl-proline (Ac-SDKP) has been shown to be hydrolyzed in vitro by ACE and to be a preferential substrate for its NH2-terminal active site. This peptide is a regulatory factor of hematopoiesis which reversibly stem cells and normal early progenitors into S-phase. We found that a single oral dose of 50 mg of the ACE inhibitor, captopril, when administered to eight healthy subjects in a double-blind, crossover, placebo-controlled study, massively increased the plasma level of Ac-SDKP. ACE inhibition by captopril induced a 90-99% inhibition of in vitro [3H]Ac-SDKP hydrolysis and a long-lasting 5.5-fold (range: 4-8.5-fold) increase in the plasma levels of Ac-SDKP. These results demonstrate that Ac-SDKP is the first natural peptide hydrolyzed by the NH2-terminal domain of ACE not only in vitro but also in vivo, confirming that both catalytic sites of ACE are physiologically active. Our data suggest that ACE may also be implicated in the process of hematopoietic stem cell regulation, by permanently degrading this natural circulating inhibitor...Continue Reading

References

Dec 1, 1990·International Journal of Radiation Oncology, Biology, Physics·W F WardJ M Hinz
Jan 1, 1987·Clinical and Experimental Hypertension. Part A, Theory and Practice·R A Skidgel, E G Erdös
Feb 1, 1989·Proceedings of the National Academy of Sciences of the United States of America·M LenfantE Frindel
Jun 1, 1985·Journal of Hypertension·D McAreaveyJ I Robertson
Jan 1, 1984·American Journal of Nephrology·H HirakataT Omae
Nov 15, 1994·International Journal of Radiation Oncology, Biology, Physics·S C YoonY W Bahk
Jan 1, 1994·Proceedings of the Society for Experimental Biology and Medicine·L NguyenA Molteni

❮ Previous
Next ❯

Citations

Jul 31, 2012·Aging Clinical and Experimental Research·Alice LaudisioUNKNOWN Gruppo Italiano di Farmacoepidemiologia nell'Anziano (GIFA) investigators
Mar 28, 2008·Journal of Molecular Medicine : Official Organ of the Gesellschaft Deutscher Naturforscher Und Ärzte·Michel Azizi
Feb 13, 2007·Clinical Research in Cardiology : Official Journal of the German Cardiac Society·Uta C Hoppe
Mar 7, 2012·Cardiovascular Drugs and Therapy·Michel Azizi, Joël Ménard
Feb 15, 2001·Current Hypertension Reports·F C Luft
Feb 13, 2001·Experimental Hematology·I Guest, J Uetrecht
Jan 29, 1999·Experimental Hematology·X M LiF Lévi
Jul 1, 1997·Trends in Endocrinology and Metabolism : TEM·C R EstherK E Bernstein
May 9, 2002·Comparative Biochemistry and Physiology. Part B, Biochemistry & Molecular Biology·Anick VandingenenRoger Huybrechts
Apr 5, 2003·The International Journal of Biochemistry & Cell Biology·Yao Sun, Karl T Weber
Apr 5, 2003·The International Journal of Biochemistry & Cell Biology·Ibrahim C Haznedaroglu, M Akif Oztürk
Oct 19, 2012·Hypertension Research : Official Journal of the Japanese Society of Hypertension·Keizo KanasakiDaisuke Koya
Feb 1, 2006·Nature Clinical Practice. Cardiovascular Medicine·Christine HubertPierre Corvol
Dec 21, 2007·Nature Clinical Practice. Nephrology·Karien van der PuttenCarlo A J M Gaillard
Mar 21, 2002·Clinical and Experimental Pharmacology & Physiology·M AziziJ Ménard
Mar 20, 1999·Kidney International. Supplement·N Muirhead
Dec 11, 2002·Kidney International·William J WelchChristopher S Wilcox
Mar 13, 2003·Kidney International·Demetrios V VlahakosNicolaos E Madias
Sep 13, 2003·Kidney International. Supplement·Carlos P Vío, Valerie A Jeanneret
Jan 22, 2003·Seminars in Dialysis·Edward F Foote, David Germick
Jun 20, 1996·The New England Journal of Medicine·N W Levin, F Gotch
Aug 21, 2003·Proceedings of the National Academy of Sciences of the United States of America·Konrad UrbanekPiero Anversa
Apr 14, 1999·Proceedings of the National Academy of Sciences of the United States of America·V DiveP Corvol
Dec 26, 2001·Current Opinion in Nephrology and Hypertension·Giuseppe Remuzzi, Norberto Perico
Mar 24, 1999·Current Opinion in Hematology·J F Prchal, J T Prchal
Nov 6, 2010·Journal of Hypertension·Nour-Eddine RhalebOscar A Carretero
Jan 29, 2013·Clinical and Experimental Pharmacology & Physiology·Ross G DouglasEdward D Sturrock
Mar 1, 2008·Clinical and Experimental Pharmacology & Physiology·Grégoire Wuerzner, Michel Azizi
Mar 23, 2006·Seminars in Dialysis·Christina Kwack, Vaidyanathapuram S Balakrishnan

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.